摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

亚异丙炔腈酸环己酯 | 37107-50-9

中文名称
亚异丙炔腈酸环己酯
中文别名
2-氰基-2-亚环己基乙酸;环己基烯氰基乙酸
英文名称
2-cyano-2-cyclohexylideneacetic acid
英文别名
cyclohexylidenecyanoacetic acid;cyano-cyclohexyliden-acetic acid;Cyan-cyclohexyliden-essigsaeure;2-cyano-2-cyclohexylidene-acetic acid;cyclohexylidene cyanoacetic acid;α-Cyan-cyclohexylidenessigsaeure
亚异丙炔腈酸环己酯化学式
CAS
37107-50-9
化学式
C9H11NO2
mdl
MFCD00013799
分子量
165.192
InChiKey
KMAMEGWTNNOKOE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    107-109°C
  • 稳定性/保质期:

    常规情况下不会分解,没有危险反应。<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.555
  • 拓扑面积:
    61.1
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 危险类别码:
    R22,R36/37/38
  • 危险品运输编号:
    UN 3276
  • 海关编码:
    2926909090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 安全说明:
    S26,S36/37/39
  • 储存条件:
    密封、阴凉、干燥、通风保存

SDS

SDS:57abcaa619ea201faff37fcab474e579
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 2-CYANO-2-CYCLOHEXYLIDENEACETIC ACID
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 37107-50-9
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Formula : C9H11NO2
Molecular Weight : 165,19 g/mol
CAS-No. : 37107-50-9
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
2-CYANO-2-CYCLOHEXYLIDENEACETIC ACID
CAS-No. 37107-50-9 Acute Tox. 4; H302 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
2-CYANO-2-CYCLOHEXYLIDENEACETIC ACID
CAS-No. 37107-50-9 Xn, R22 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing 110 - 110,5 °C
point
f) Initial boiling point and 129 - 130 °C
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 1,516
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    亚异丙炔腈酸环己酯氯化亚砜 作用下, 以 为溶剂, 反应 5.25h, 生成 1-(4-hydroxyphenyl)-5-cyano-4-oxo-2-thioxo-1,3-diazaspiro<5,5>undecane
    参考文献:
    名称:
    Dzurilla, Milan; Forgac, Ondrej; Kutschy, Peter, Collection of Czechoslovak Chemical Communications, 1987, vol. 52, # 4, p. 989 - 994
    摘要:
    DOI:
  • 作为产物:
    描述:
    2-环己基亚己基丙二腈盐酸盐酸羟胺 、 sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 15.0h, 生成 亚异丙炔腈酸环己酯
    参考文献:
    名称:
    在水中的多米诺反应和2,3-二氢异恶唑的意外开环反应合成功能化的2,3-二氢异恶唑† ‡
    摘要:
    α,α-二氰基烯烃与 羟胺可以在温和,环境友好的条件下以极好的收率得到2,3-二氢异恶唑(2,3-二氢异恶唑可以很容易地通过过滤分离)。也已经开发出一锅反应与意外的2,3-二氢异恶唑开环反应。
    DOI:
    10.1039/c1ob06318a
点击查看最新优质反应信息

文献信息

  • [EN] FUSED THIOPHENE DERIVATIVES AND THEIR USES<br/>[FR] DÉRIVÉS DE THIOPHÈNE CONDENSÉS ET LEURS UTILISATIONS
    申请人:ENYO PHARMA
    公开号:WO2019154949A1
    公开(公告)日:2019-08-15
    The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    本发明涉及一类新的融合噻吩衍生物,以及它们在治疗感染、癌症、代谢性疾病、心血管疾病、铁储存障碍和炎症性疾病方面的用途。
  • Cinétique et mécanisme de la réaction de knoevenagel dans le benzène-2
    作者:J. Guyot、A. Kergomard
    DOI:10.1016/s0040-4020(01)91880-0
    日期:1983.1
    The kinetics of the reaction of ( + )-3-methyl cyclohexanone with malononitrile were studied in benzene at 25°, in the presence of hexylamine-acetic acid mixtures. Hexylamine gives an imine with cyclohexanone in an acid-catalysed step. This imine then reacts quickly with malononitrile. A rate law of zero order in malononitrile is observed. Separate kinetic results obtained for the formation of the
    在己胺-乙酸混合物的存在下,于25°在苯中研究了(+)-3-甲基环己酮与丙二腈的反应动力学。己胺在酸催化的步骤中生成带有环己酮的亚胺。然后,该亚胺与丙二腈快速反应。丙二腈中观察到零级速率定律。亚胺形成和亚胺-丙二腈反应获得的单独动力学结果支持了该机理。如果没有乙酸,则观察到复杂的速率定律。己胺主要起碱性催化剂的作用。伯胺羧酸在Knoevenagel反应中用作催化剂,与更常用的催化剂:哌啶,β-丙氨酸,AcOH-AcONH 4相比,通常可提高收率并缩短反应时间。
  • α-Isocyanatoacrylonitriles from Alkylidene- or Arylidenecyanoacetic Acids; Synthesis and Reactions
    作者:Ihsan Jaafar、Georges Francis、Renée Danion-Bougot、Daniel Danion
    DOI:10.1055/s-1994-25405
    日期:——
    The Curtius reaction converts alkylidene- or arylidenecyanoacetic acids to α-isocyanatoacrylonitriles in a stereospecific way. These versatile intermediates allow an easy access to arylacetic acids and various amino acid derivatives, as well as β-lactams or 2-azabutadienes.
    Curtius 反应以立体特异性的方式将亚烷基或亚芳基氰基乙酸转化为δ-异氰酸基丙烯腈。通过这些多功能中间体,可以很容易地获得芳基乙酸和各种氨基酸衍生物,以及δ-内酰胺或 2-氮杂丁二烯。
  • [EN] INGENOL-3-ACYLATES I<br/>[FR] INGÉNOL-3-ACYLATES I
    申请人:LEO PHARMA AS
    公开号:WO2012085189A1
    公开(公告)日:2012-06-28
    The invention relates to compounds of general formula (I) wherein R is (C1-C7)alkyl, (C2-C7)alkenyl or (C2-C7)alkynyl; wherein R is substituted with R1; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.
    本发明涉及一般式(I)的化合物,其中R为(C1-C7)烷基,(C2-C7)烯基或(C2-C7)炔基;其中R被R1取代;以及其药学上可接受的盐、水合物或溶剂化物,用于治疗、预防、治疗或改善对中性粒细胞氧化爆发刺激、角质细胞IL-8释放刺激或坏死诱导反应敏感的疾病或病情,可以单独使用或与一个或多个其他药物活性化合物结合使用。
  • Method for making bicycle lactones from beta, gamma unsaturated cyclic
    申请人:Angus Chemical Company
    公开号:US04772728A1
    公开(公告)日:1988-09-20
    A method for making a bicyclic lactone comprising heating under aqueous acidic conditions a beta, gamma unsaturated cyclic nitrile and an aldehyde, for a length of time sufficient to convert at least a portion of the reactants to a bicyclic lactone of the formula ##STR1## wherein R.sub.3 is --H; R.sub.4, R.sub.5, and R.sub.6 are independently selected from the group consisting of --H, --CH.sub.3 ; R.sub.2 is selected from the group consisting of --H, --CH.sub.3, and --CH.sub.3, and --C.sub.2 H.sub.5 ; R.sub.8 is --H or --CH.sub.3 ; m is an integer from 1 to 5; o is 0, 1, 2, or 3; and p is 0, 1, or 2; provided that the sum of m+o+p is an integer from 3 to 5; either R.sub.3 or R.sub.8 together with R.sub.7 represents a carbon-carbon bond. The method uses commercially available and relatively inexpensive raw materials as reactants.
    一种制备双环内酯的方法,包括在水性酸性条件下加热β,γ-不饱和环状腈和醛,时间足够长以将反应物的至少一部分转化为式为##STR1##的双环内酯,其中R.sub.3为--H;R.sub.4,R.sub.5和R.sub.6分别选自--H,--CH.sub.3的群;R.sub.2选自--H,--CH.sub.3和--CH.sub.3,--C.sub.2 H.sub.5的群;R.sub.8为--H或--CH.sub.3;m为1到5的整数;o为0、1、2或3;p为0、1或2;前提是m+o+p的总和是3到5的整数;R.sub.3或R.sub.8与R.sub.7一起表示碳-碳键。该方法使用商业上可获得和相对廉价的原材料作为反应物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物